Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.

Spatial transcriptomics leverages omics techniques to extract transcriptome data while retaining the context of the original tissue, aiding disease research, biomarker development, and understandings of tissue structures and cellular heterogeneity.

Recent studies have used multiplex blood biomarker information from patients to distinguish individual patient subgroups for neurodegenerative diseases, helping to stratify patients by their pathology.

Here, we discuss the development and application of multiplex immunofluorescence-based biomarker strategies to study the tumour microenvironment in lymphoma patients, exploring how these approaches can help to identify immune cell interactions.

Researchers from MIT have developed a wearable ultrasound patch that can image breast tissue, potentially facilitating the home detection of breast cancer. The patch can be attached a bra, and shows promise in detecting small cysts.

N-of-1 trials employ individualised treatments through double-blinded, randomised sequences to determine optimal approaches and enhance patient-doctor collaboration.

Diagnostic biomarkers offer a crucial means of tracking disease spread and progression. Here, we explore their application in age-related diseases, as well as inflammatory diseases such as Crohn’s.

While biomarkers are integral to the identification and validation of disease treatment methods, there is a disconnect between existing validation approaches and their applications in commercialisation.